Jan 08, 2018 12:31 pm UTC| Business
US IND Filing Expected in the First Half of 2018 Hengrui is Eligible to Receive Collaboration and Licensing Payments of Approximately $350MM, in Addition to Royalties on Future Sales NEW YORK and SHANGHAI, China, Jan. ...
Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance
Jan 08, 2018 12:31 pm UTC| Business
310+ People with Fabry Disease Treated with Reimbursed Galafold® at YE17 FY18 Galafold Revenue Guidance of $75M-$85M Regulatory Agreement on Comparability of 1,000L Scale Engineering Material for Pompe ...
Jan 08, 2018 12:31 pm UTC| Business
- Dr. Ludwig brings over 20 years of leadership and management expertise from Eli Lilly and Company and Imclone Systems, Inc. in oncology antibody therapeutics discovery and development where he supported the development...
Jan 08, 2018 12:30 pm UTC| Business
TORONTO, Jan. 08, 2018 -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time MR imaging combined...
Valeritas Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results
Jan 08, 2018 12:30 pm UTC| Business
BRIDGEWATER, N.J., Jan. 08, 2018 -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable,...
Jan 08, 2018 12:30 pm UTC| Business
NEWTOWN, Pa., Jan. 08, 2018 -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, announced today that...
McDermott Updates Investors Regarding Proposed Combination
Jan 08, 2018 12:30 pm UTC| Business
HOUSTON, Jan. 08, 2018 -- McDermott International, Inc. (NYSE:MDR) today provided an updated investor presentation regarding its proposed combination with CBI (NYSE:CBI) which was announced on December 18, 2017. The...